19 January 2017
News and Views
Links and Services
Teduglutide reduces the need for parenteral fluids among patients with short bowel syndrome with intestinal failure, reports December's issue of Gastroenterology.
Teduglutide, a glucagon-like peptide 2 analogue, might restore intestinal structural and function
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors